Keyphrases
Type 2 Diabetes Mellitus (T2DM)
78%
Type 2 Diabetic Patients
67%
Web-based Study
58%
Preference Study
58%
Pregnant Women
58%
Drug Effects
58%
Turkey
58%
Netherlands
58%
Chronic Disease
58%
Medication Beliefs
58%
Relative Weight
58%
Maximum Acceptable Risk
58%
Glucose-lowering Drugs
58%
Decision Aid
58%
Antidiabetic Drugs
39%
Epilepsy
39%
During Pregnancy
39%
Beliefs about Medicines Questionnaire
39%
Inflammatory Bowel Disease
39%
Allergy
39%
Hypoglycemic Events
29%
Gastrointestinal
29%
Medicine Acceptability
29%
Cardiovascular Risk
28%
Patient Preference
28%
Drug Class
25%
No Significant Difference
19%
Treatment Decisions
19%
Positive Beliefs
19%
Rheumatic Diseases
19%
Diabetes
19%
Adverse Drug Events
19%
Women with children
19%
Counseling
19%
High-score
19%
Medication Use
19%
Discrete Choice Experiment
19%
Web-based Survey
19%
European Countries
19%
Europe
19%
1-year-olds
19%
Asthma
19%
Risk Reduction
19%
Web-based
16%
Shared Decision Making
16%
Comprehensibility
16%
Drug Characteristics
16%
Multinomial Logit Model
9%
Regulatory Decisions
9%
Cardiovascular Disease
9%
Pharmacology, Toxicology and Pharmaceutical Science
Oral Antidiabetic Agent
58%
Sodium Glucose Cotransporter 2 Inhibitor
58%
Adverse Drug Reaction
58%
Combination Therapy
58%
Adverse Event
58%
Drug Safety
58%
Alzheimer's Disease
58%
Non Insulin Dependent Diabetes Mellitus
58%
Non Insulin Dependent Diabetes Mellitus
58%
Cross Sectional Study
52%
Antidiabetic Agent
44%
Cardiovascular Disease
44%
Pharmacovigilance
29%
Risk Communication
29%
Hemoglobin A1c
14%
Bladder Cancer
14%
Hypoglycemia
9%
Metformin
9%
Glucagon-Like Peptide-1
9%
Cardiovascular Disease
9%
Disease
8%
Disease Exacerbation
8%
Nursing and Health Professions
Drug Therapy
100%
Chronic Disease
88%
Alzheimer's Disease
88%
Patient with Type 2 Diabetes
70%
Combination Therapy
58%
Adverse Event
58%
Non Insulin Dependent Diabetes Mellitus
58%
Disease
31%
Clinical Practice
29%
Shared Decision-Making
23%
Confidence Interval
16%
Inflammatory Bowel Disease
11%
Practice Guideline
11%
Thematic Analysis
11%
Glucagon Like Peptide 1
11%
Cardiovascular Disease
11%
Hypoglycemia
11%
Metformin
11%
Patient Preference
11%
Disease Exacerbation
8%
Allergic Asthma
5%
Cross-Sectional Study
5%
Rheumatic Disease
5%